Stockreport
CHF Solutions, Inc. Begins New Educational Program, “Facing the Facts About Fluid Overload” to Demonstrate the Need for Aquadex Therapy
US:NASDAQ Investor Relations: ir.sunshineheart.com/investor-relations
PDF
EDEN PRAIRIE, Minn., March 29, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS) announced today the launch of a new educational program, “Facing the Facts About Fluid Overload,” designed to inform providers about an alternative ultrafiltration therapy for heart failure patients with fluid overload who have failed diuretic therapy. "Intravenous diuretics have been the standard of care for heart failure patients with fluid overload since the 1950s1,2, but data demonstrates that 68 percent of patients experience a less than optimal response, and approximately 40 percent are resistant to diuretic therapy3. Many physicians simply are not aware that the Aquadex FlexFlow System can address the unmet clinical need for these patients when diuretic resistance is encountered,” commented Jim Breidenstein, chief commercial officer of CHF Solutions. “This educational program provides clinicians with compelling data about the limitations of IV diuretics, and the importance of having
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | CHFS | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
CHFS alerts
CHFS alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
CHFS alerts
High impacting CHF SOLUTIONS INC news events
Weekly update
A roundup of the hottest topics
CHFS
NEWS
NEWS
- Recently Presented Data Demonstrate Benefits of CHF Solutions’ Aquadex FlexFlow® System in Managing Fluid Overload in Heart Failure Patients from the United Kingdom[GlobeNewswire]
- CHF Solutions Expands Commercial Focus of Fluid Overloaded Patients into the Post-Cardiovascular Surgery Market[GlobeNewswire]
- CHF Solutions Inc (NASDAQ: CHFS) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.[MarketBeat]
- CHF Solutions, Inc. to Attend the 22nd Annual Scientific Meeting of the Heart Failure Society of America[GlobeNewswire]
- CHF Solutions, Inc. acquires impedance technology from Vasamed, Inc. [Seeking Alpha][Seeking Alpha]
- More
CHFS
SEC Filings
SEC Filings
- 8/13/18 - Form 4
- 8/9/18 - Form 10-Q
- 8/7/18 - Form 8-K
- CHFS's page on the SEC website
- More